Bukwang Pharm (003000) — Cash Flow Reinvestment Rate
Bukwang Pharm (003000) has a Cash Flow Reinvestment Rate of 2.10x as of June 2025, reinvesting ₩21.05 Billion (capex ₩2.80 Billion plus investments ₩-18.25 Billion) from operating cash flow of ₩10.03 Billion. Check Bukwang Pharm (003000) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bukwang Pharm Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Bukwang Pharm across 10 annual periods. Explore Bukwang Pharm strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Bukwang Pharm (2007–2024)
Year-by-year capital reinvestment analysis for Bukwang Pharm. For live market cap and broader valuation context, see Bukwang Pharm stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.17x | ₩40.11 Billion | ₩34.36 Billion | ₩2.61 Billion | ▲ +136.0% |
| 2022 | 0.49x | ₩8.14 Billion | ₩16.46 Billion | ₩4.99 Billion | ▲ +121.0% |
| 2021 | 0.22x | ₩5.94 Billion | ₩26.52 Billion | ₩785.05 Million | ▼ -96.8% |
| 2020 | 7.09x | ₩5.13 Billion | ₩723.17 Million | ₩1.92 Billion | ▲ +14.4% |
| 2018 | 6.20x | ₩42.27 Billion | ₩6.82 Billion | ₩3.71 Billion | ▲ +830.9% |
| 2017 | 0.67x | ₩5.70 Billion | ₩8.56 Billion | ₩4.49 Billion | ▼ -25.6% |
| 2015 | 0.89x | ₩9.21 Billion | ₩10.30 Billion | ₩4.58 Billion | ▲ +343.3% |
| 2014 | 0.20x | ₩5.62 Billion | ₩27.86 Billion | ₩2.97 Billion | ▼ -76.3% |
| 2013 | 0.85x | ₩31.14 Billion | ₩36.52 Billion | ₩3.74 Billion | ▲ +14.9% |
| 2007 | 0.74x | ₩20.69 Billion | ₩27.87 Billion | ₩20.69 Billion | — |